文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

辣椒素 8%贴剂 Qutenza 和其他用于治疗化疗引起的周围神经病变性疼痛(CIPN)的现有治疗方法。

Capsaicin 8% patch Qutenza and other current treatments for neuropathic pain in chemotherapy-induced peripheral neuropathy (CIPN).

机构信息

Division of Neurology, Imperial College London, Hammersmith Hospital, London, UK.

出版信息

Curr Opin Support Palliat Care. 2021 Jun 1;15(2):125-131. doi: 10.1097/SPC.0000000000000545.


DOI:10.1097/SPC.0000000000000545
PMID:33905384
Abstract

PURPOSE OF REVIEW: Current oral treatments for neuropathic pain associated with chemotherapy-induced peripheral neuropathy (CIPN) have limited clinical efficacy, and undesirable side-effects. Topically delivered treatments have the advantage of avoiding CNS side-effects, while relieving pain. We have reviewed treatments of neuropathic pain associated with CIPN, focusing on the Capsaicin 8% patch, which can provide pain relief for up to 3 months or longer after a single 30-60-min application. RECENT FINDINGS: Capsaicin 8% patch is a licensed treatment in the EU/UK for neuropathic pain and shown to be safe and effective in providing pain relief for patients with CIPN. Repeated daily oral or topical administrations are not required, as with other current treatments. The side-effects are transient and restricted to the time around patch application. New evidence suggests the Capsaicin 8% patch can promote the regeneration and restoration of skin nerve fibres in CIPN, in addition to the pain relief. SUMMARY: The Capsaicin 8% patch is now often a preferred a treatment option for localised neuropathic pain conditions, including the feet and hands in patients with CIPN. Capsaicin 8% patch can be repeated three-monthly, if needed, for a year. In addition to pain relief, it may have a disease-modifying effect.

摘要

目的综述:目前用于治疗化疗引起的周围神经病变性疼痛(CIPN)的口服药物疗效有限,且有不良反应。局部给药的优点是可以避免中枢神经系统的副作用,同时缓解疼痛。我们回顾了与 CIPN 相关的神经病理性疼痛的治疗方法,重点介绍了 8%辣椒素贴片,单次使用 30-60 分钟后,其止痛效果可持续长达 3 个月或更长时间。

最新研究进展:8%辣椒素贴片在欧盟/英国被批准用于治疗神经病理性疼痛,并且已被证明对 CIPN 患者的疼痛缓解安全有效。与其他当前治疗方法不同,不需要每日重复口服或局部使用。其副作用是短暂的,仅局限于贴片应用期间。新证据表明,8%辣椒素贴片除了缓解疼痛外,还可以促进 CIPN 中皮肤神经纤维的再生和修复。

总结:8%辣椒素贴片现在通常是局部神经病理性疼痛(包括 CIPN 患者手部和足部疼痛)的首选治疗方法。如果需要,该贴片可每 3 个月重复使用一次,持续 1 年。除了缓解疼痛外,它可能还有疾病修饰作用。

相似文献

[1]
Capsaicin 8% patch Qutenza and other current treatments for neuropathic pain in chemotherapy-induced peripheral neuropathy (CIPN).

Curr Opin Support Palliat Care. 2021-6-1

[2]
Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification.

J Pain Res. 2019-7-3

[3]
Adhesive capsaicin 8% patch for improved control of pain caused by chemotherapy-induced peripheral neuropathy in patients with multiple myeloma: A single-centre, seven-case series.

J Oncol Pharm Pract. 2024-6

[4]
Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.

Drugs. 2018-9

[5]
Topical treatment of chemotherapy-induced peripheral neuropathy (CIPN) with high-concentration (179 mg) capsaicin patch in breast cancer patients - results of the QUCIP study.

Front Oncol. 2024-9-6

[6]
Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.

Curr Med Res Opin. 2017-8

[7]
Posttraumatic and postsurgical neuropathic pain responsive to treatment with capsaicin 8% topical patch.

Pain Physician. 2014

[8]
Topical capsaicin (high concentration) for chronic neuropathic pain in adults.

Cochrane Database Syst Rev. 2013-2-28

[9]
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults.

Expert Rev Neurother. 2021-3

[10]
Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy.

Expert Rev Neurother. 2021-10

引用本文的文献

[1]
Emerging treatments for chronic neuropathic pain from a cross-disease perspective: developments and applications of nanomaterials.

J Headache Pain. 2025-6-17

[2]
Vascular and nerve biomarkers in thigh skin biopsies differentiate painful from painless diabetic peripheral neuropathy.

Front Pain Res (Lausanne). 2024-10-25

[3]
Making Sense of Topical Pain Relief Options: Comparing Topical Analgesics in Efficacy and Safety.

Sports Health. 2024-10-26

[4]
Contributions of neuroimmune interactions to chemotherapy-induced peripheral neuropathy development and its prevention/therapy.

Biochem Pharmacol. 2024-4

[5]
TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases.

Signal Transduct Target Ther. 2023-7-5

[6]
Parthenolide as a potential analgesic in the treatment of paclitaxel-induced neuropathic pain: the rat modeling.

Naunyn Schmiedebergs Arch Pharmacol. 2023-12

[7]
Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain.

Int J Mol Sci. 2023-2-18

[8]
Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: Clinical evidence for pain relief and restoration of function nerve fiber regeneration.

Front Neurol. 2022-10-26

[9]
Traditional processing increases biological activities of Dendrobium offificinale Kimura et. Migo in Southeast Yunnan, China.

Sci Rep. 2022-8-31

[10]
Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer.

Front Oncol. 2022-7-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索